Claims for Patent: 9,018,448

Summary for Patent: 9,018,448

Title:	Woody plants having improved growth characteristics and method for making the same
Abstract:	The present invention pertains to a novel and extensive analytical platform for selecting genes with a possible commercial phenotype from a large group of candidate genes identified using tools in bioinformatics, data from EST sequencing and DNA array. An aspect of the invention provides a method of producing a transgenic plant having an increased growth compared to its wild type. The method comprises altering in the plant the level of a gene product of at least one gene specifically expressed during different phases of wood formation. Further aspects of the invention provide a plant cell or plant progeny of a transgenic plant comprising a recombinant polynucleotide according to the invention. Other aspects pertain a DNA construct comprising a nucleotide sequence of the invention and a plant cell or plant progeny comprising the DNA construct.
Inventor(s):	Hertzberg; Magnus (Umea, SE), Sandberg; Goran (Umea, SE), Schrader; Jarmo (Umea, SE), Jonsen; Carl David (Umea, SE)
Assignee:	SweTree Technologies AB (Umea, SE)
Application Number:	12/518,086
Patent Claims:	1. A method of producing a transgenic tree, the method comprising; transforming one or more regenerable cells of a tree expressing a gene product encoded by the nucleotide sequence of SEQ ID NO:15 with a recombinant DNA construct, such that the expression of the gene product encoded by the nucleotide sequence SEQ ID NO: 15 is suppressed, wherein the expression is suppressed by RNA interference, and wherein the RNA interference is effected by an RNA polynucleotide that is at least 95% identical to an at least 30 consecutive nucleotide portion of an RNA transcript of SEQ ID NO: 15. 2. The method according to claim 1, wherein said recombinant DNA construct comprises a nucleotide sequence selected from the group consisting of: a) the polynucleotide sequence of SEQ ID NO: 36; b) a complementary polynucleotide sequence of the entire polynucleotide sequence of a); and c) a polynucleotide sequence of at least 30 consecutive nucleotide residues, that is at least 95% identical to a 30 nucleotide sub-sequence of the polynucleotide sequence of a) or b). 3. The method according to claim 2, wherein the recombinant DNA construct further comprises a promoter selected from the group consisting of a constitutive promoter, an inducible promoter, and a tissue specific promoter, wherein the promoter is operably linked to said nucleotide sequence. 4. The method according to claim 2, wherein the recombinant DNA construct further comprises a strong constitutive promoter in front of a transcribed cassette comprising a nucleotide sequence as defined in claim 2, followed by a plant functional intron, and followed by the nucleotide sequence as defined in claim 2 in reverse orientation. 5. The method according to claim 1, the method further comprising regenerating a transgenic plant from said one or more regenerable cells. 6. The method according to claim 1, wherein the transgenic tree is a hardwood tree and wherein the hardwood tree is selected from the group consisting of acacia, eucalyptus, hornbeam, beech, mahogany, walnut, oak, ash, willow, hickory, birch, chestnut, poplar, alder, maple, sycamore, ginkgo, a palm tree and sweet gum. 7. The method according to claim 1, wherein the transgenic tree is a hardwood tree and wherein the hardwood tree is a plant of the Salicaceae family. 8. The method according to claim 1, wherein the tree is a conifer. 9. The method according to claim 8, wherein the conifer is selected from the group consisting of cypress, Douglas fir, fir, sequoia, hemlock, cedar, juniper, larch, pine, redwood, spruce and yew. 10. The method according to claim 1, wherein the tree is a fruit bearing tree. 11. The method according to claim 1, wherein the tree is selected from the group consisting of bamboo and rubber plants. 12. The method of claim 1, wherein the one or more regenerable cells are from a Populus tremula tree.

Details for Patent 9,018,448

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2026-12-08
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2026-12-08
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2026-12-08